Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)

Federal funding opportunity RFA-CA-24-024 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• Public and State controlled institutions of higher education
• Private institutions of higher education
• County governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Special district governments
• Public housing authorities/Indian housing authorities
• Independent school districts
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• City or township governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• State governments
• Small businesses
• Native American tribal organizations (other than Federally recognized tribal governments)
• Native American tribal governments (Federally recognized)
• For profit organizations other than small businesses

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

The official record

Similar grants

• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  PAR-25-167 · National Institutes of Health · closes January 7, 2027
• Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
  PAR-25-103 · National Institutes of Health · closes October 25, 2027
• Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
  PAR-25-104 · National Institutes of Health · closes October 25, 2027
• National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
  PAR-25-081 · National Institutes of Health · closes January 7, 2027
• Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
  PAR-25-145 · National Institutes of Health · closes January 7, 2028
• Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
  RFA-CA-26-010 · National Institutes of Health